Other CMA substrates, such as synuclein α, tau, and huntingtin, are involved in different brain cellular functions, and the alteration of the expression of these factors is linked to diverse degenerative diseases, including Parkinson disease (PD), Alzheimer’s disease (AD), and Huntington disease (HD). This evidence concerns the gene MAPT and Alzheimer disease.